- Regulation
- Technology
- Resources
Latest News
-
FDA PreCheck launches to strengthen domestic drug manufacturing
The FDA has unveiled FDA PreCheck, a two-phase program designed to speed approvals and boost regulatory certainty for US drug manufacturing projects.
-
US-Japan tariff dispute – lessons for compliance
Japan’s reciprocal tariff agreement with the US underscores how fragile trade commitments can create layered compliance risk.
-
CVS Caremark’s $95m penalty for Medicare drug overbilling
Whistleblower alleged Caremark reported higher costs of drugs to the government than it paid pharmacies for dispensing Medicare Part D drugs.
-
UK investing in “strategic” AI capabilities
OpenBind consortium, new Centre for AI-driven innovation, and supercomputer funding all intended to help drive drug R&D
-
GRIP Extra: SEC to cut enforcement staff by 17%, Wells Fargo freed from asset cap
Our in-brief roundup also includes Bristol Myers Squibb and BioNTech in a drug partnership, Reddit suing Anthropic for using its data, and BlackRock being removed from Texas blacklist.
-
GRIP Extra: Bitcoin hits record high, SEC commissioner slams deregulation
Other news includes China threatening legal action against companies taking US guidance not to buy Chinese chips, and the UK sanctioning an accountant for buying oil tankers for Lukoil.
-
Drug prices in executive and legislative cross-hairs
The rising cost of prescription drugs is a concern for patients, healthcare providers and policymakers, but crafting a solution without undermining industry confidence is tricky.
-
GRIP Extra: Coinbase victim of $400m cyberattack, Trump fires Copyright Office director
Other news includes Nvidia planning an R&D center in Shanghai, the SEC and FINRA withdrawing a joint crypto custody statement, and the CEO of Novo Nordisk stepping down.